These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys. McMahon LR; France CP J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581 [TBL] [Abstract][Full Text] [Related]
3. Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys. McMahon LR; France CP Br J Pharmacol; 2006 Feb; 147(3):260-8. PubMed ID: 16331290 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. Whittemore ER; Yang W; Drewe JA; Woodward RM Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369 [TBL] [Abstract][Full Text] [Related]
5. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077 [TBL] [Abstract][Full Text] [Related]
6. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors. Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902 [TBL] [Abstract][Full Text] [Related]
7. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. McMahon LR; Gerak LR; France CP J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825 [TBL] [Abstract][Full Text] [Related]
8. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs. Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789 [TBL] [Abstract][Full Text] [Related]
9. Chronic benzodiazepine treatment does not alter interactions between positive GABA(A) modulators and flumazenil or pentylenetetrazole in monkeys. Gerak LR; France CP Behav Pharmacol; 2011 Feb; 22(1):49-57. PubMed ID: 21516176 [TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of GABAA receptors via multiple drug-binding sites. Sieghart W Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367 [TBL] [Abstract][Full Text] [Related]
11. Antagonism of the discriminative stimulus effects of positive gamma-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam. Lelas S; Gerak LR; France CP J Pharmacol Exp Ther; 2000 Sep; 294(3):902-8. PubMed ID: 10945839 [TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105 [TBL] [Abstract][Full Text] [Related]
13. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Pistis M; Belelli D; Peters JA; Lambert JJ Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818 [TBL] [Abstract][Full Text] [Related]
14. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines. Reynolds DS Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867 [TBL] [Abstract][Full Text] [Related]
15. Relative positioning of diazepam in the benzodiazepine-binding-pocket of GABA receptors. Tan KR; Baur R; Charon S; Goeldner M; Sigel E J Neurochem; 2009 Dec; 111(5):1264-73. PubMed ID: 19804380 [TBL] [Abstract][Full Text] [Related]
16. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt. Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of type A GABA receptors by L-type calcium channel blockers. Das P; Bell-Horner CL; Huang RQ; Raut A; Gonzales EB; Chen ZL; Covey DF; Dillon GH Neuroscience; 2004; 124(1):195-206. PubMed ID: 14960351 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test. Mathiasen LS; Rodgers RJ; Mirza NR Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483 [TBL] [Abstract][Full Text] [Related]
20. Neuroactive steroid actions at the GABAA receptor. Lan NC; Gee KW Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]